| Year |
Title |
Altmetric |
| 2023
|
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study..
JCO Precision Oncology.
7:e2200505.
2023
|
|
| 2023
|
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials..
Jco Oncology Practice.
OP2200378.
2023
|
|
| 2023
|
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer.
Clinical Cancer Research.
29:50-59.
2023
|
|
| 2023
|
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Breast Cancer Research and Treatment.
2023
|
|
| 2022
|
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.
Nature Communications.
13.
2022
|
|
| 2022
|
An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.
JCI Insight.
7.
2022
|
|
| 2022
|
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B..
JCO Precision Oncology.
6:e2200165.
2022
|
|
| 2022
|
The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells.
Frontiers in Oncology.
12.
2022
|
|
| 2022
|
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
Journal of Clinical Oncology.
111.
2022
|
|
| 2022
|
Poly(N-vinylpyrrolidone)- block-Poly(dimethylsiloxane)- block-Poly(N-vinylpyrrolidone) Triblock Copolymer Polymersomes for Delivery of PARP1 siRNA to Breast Cancers.
ACS Applied Bio Materials.
5:1670-1682.
2022
|
|
| 2022
|
Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer.
Cancers.
14.
2022
|
|
| 2022
|
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.
Clinical Cancer Research.
28:327-337.
2022
|
|
| 2021
|
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Breast Cancer Research.
23.
2021
|
|
| 2021
|
RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity
2021
|
|
| 2021
|
Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer.
Frontiers in Oncology.
11.
2021
|
|
| 2021
|
Anti-cd47 monoclonal antibody–drug conjugate: A targeted therapy to treat triple-negative breast cancers.
Vaccines.
9.
2021
|
|
| 2021
|
Gene expression signature correlates with outcomes in metastatic renal cell carcinoma patients treated with everolimus alone or with a vascular disrupting agent.
Molecular Cancer Therapeutics.
20:1454-1461.
2021
|
|
| 2021
|
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples..
JCO Precision Oncology.
5.
2021
|
|
| 2021
|
Targeted liposomal chemotherapies to treat triple-negative breast cancer.
Cancers.
13.
2021
|
|
| 2021
|
The bet inhibitor JQ1 augments the antitumor efficacy of gemcitabine in preclinical models of pancreatic cancer.
Cancers.
13.
2021
|
|
| 2021
|
A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.
Radiotherapy and Oncology.
157:203-209.
2021
|
|
| 2021
|
PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1.
Oncogene.
40:2448-2462.
2021
|
|
| 2021
|
Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy.
Acta Biotechnologica.
21:37-44.
2021
|
|
| 2021
|
Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.
Supportive Care in Cancer.
29:263-269.
2021
|
|
| 2021
|
Targeting DNA repair pathways to overcome cancer drug resistance
2021
|
|
| 2020
|
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.
Journal for ImmunoTherapy of Cancer.
8.
2020
|
|
| 2020
|
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Journal of Clinical Oncology.
38:4274-4282.
2020
|
|
| 2020
|
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Nature Communications.
11.
2020
|
|
| 2020
|
Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study.
Archives of Osteoporosis.
15.
2020
|
|
| 2020
|
Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth.
Frontiers in Genetics.
11.
2020
|
|
| 2020
|
CHK1/2 inhibitor prexasertib suppresses notch signaling and enhances cytotoxicity of cisplatin and radiation in head and neck squamous cell carcinoma.
Molecular Cancer Therapeutics.
19:1279-1288.
2020
|
|
| 2020
|
Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.
International Journal of Cancer.
146:2784-2796.
2020
|
|
| 2020
|
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.
Oncogene.
39:4077-4091.
2020
|
|
| 2020
|
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R.
Oncogenesis.
9.
2020
|
|
| 2020
|
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
PLoS One.
15.
2020
|
|
| 2020
|
Combined targeting of mutant p53 and jumonji family histone demethylase augments therapeutic efficacy of radiation in H3K27M DIPG.
International Journal of Molecular Sciences.
21.
2020
|
|
| 2020
|
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
Therapeutic Advances in Medical Oncology.
12.
2020
|
|
| 2019
|
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG
2019
|
|
| 2019
|
Feasibility of Dose Escalating [18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer.
Advances in Radiation Oncology.
4:649-658.
2019
|
|
| 2019
|
The pros and cons of incorporating transcriptomics in the age of precision oncology
2019
|
|
| 2019
|
WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.
American Journal of Transplantation.
19:2833-2845.
2019
|
|
| 2019
|
Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.
Biochemical and Biophysical Research Communications.
517:36-42.
2019
|
|
| 2019
|
Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies.
Genes and Diseases.
6:232-246.
2019
|
|
| 2019
|
Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans.
Nutrients.
11.
2019
|
|
| 2019
|
The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors.
EBioMedicine.
44:419-430.
2019
|
|
| 2019
|
Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.
Journal of the American College of Radiology.
16:315-320.
2019
|
|
| 2019
|
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.
Advances in Radiation Oncology.
4:90-95.
2019
|
|
| 2019
|
Targeting DNA repair in precision medicine.
Advances in protein chemistry and structural biology.
115:135-155.
2019
|
|
| 2018
|
The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
Cancer.
124:4657-4666.
2018
|
|
| 2018
|
First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibition.
Journal of the National Comprehensive Cancer Network : JNCCN.
16:1166-1170.
2018
|
|
| 2018
|
Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
European urology focus.
4:733-736.
2018
|
|
| 2018
|
Reply to "phase II prospective randomized trial of weight loss prior to radical prostatectomy.
Prostate Cancer and Prostatic Diseases.
21:293-294.
2018
|
|
| 2018
|
Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma.
Molecular Cancer Research.
16:813-824.
2018
|
|
| 2018
|
Trastuzumab-resistant HER2 þ breast cancer cells retain sensitivity to poly (adp-ribose) polymerase (parp) inhibition.
Molecular Cancer Therapeutics.
17:921-930.
2018
|
|
| 2018
|
Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case Examples..
Cureus.
10:e2524.
2018
|
|
| 2018
|
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer [Oncotarget., 7, (2016) (86803-86815)] 10.18632/oncotarget.13466.
Oncotarget.
9:19459-19459.
2018
|
|
| 2018
|
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
Journal of Biological Chemistry.
293:984-994.
2018
|
|
| 2018
|
JQ1 induces DNA damage and apoptosis, and inhibits tumor growth in a patient-derived xenograft model of cholangiocarcinoma.
Molecular Cancer Therapeutics.
17:107-118.
2018
|
|
| 2017
|
Non-coding MIR491 is associated with less EGFr expression and greater radiosensitivity in human head and neck cancer cell lines.
Annals of Oncology.
28:x6.
2017
|
|
| 2017
|
Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.
Urologic Oncology: seminars and original investigations.
35:663.e15-663.e21.
2017
|
|
| 2017
|
The impact of DNA repair pathways in cancer biology and therapy.
Cancers.
9.
2017
|
|
| 2017
|
DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy.
Oncotarget.
8:68038-68046.
2017
|
|
| 2017
|
DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy..
Oncotarget.
8:68038-68046.
2017
|
|
| 2017
|
Implementation and utilization of the molecular tumor board to guide precision medicine..
Oncotarget.
8:57845-57854.
2017
|
|
| 2017
|
A step towards predicting checkpoint inhibitor response in kidney cancer
2017
|
|
| 2017
|
Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project.
Journal of Inherited Metabolic Disease.
40:403-414.
2017
|
|
| 2017
|
Combining Chk1/2 inhibition with cetuximab and radiation enhances in vitro and in vivo cytotoxicity in head and neck squamous cell carcinoma.
Molecular Cancer Therapeutics.
16:591-600.
2017
|
|
| 2017
|
CT measures of bone mineral density and muscle mass can Be used to predict noncancer death in men with prostate cancer.
Radiology.
282:475-483.
2017
|
|
| 2017
|
Let-7 status is crucial for PARP1 expression in HER2-overexpressing breast tumors.
Molecular Cancer Research.
15:340-347.
2017
|
|
| 2017
|
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.
Oncology Letters.
13:1216-1222.
2017
|
|
| 2017
|
Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Seminars in Cell and Developmental Biology.
63:144-153.
2017
|
|
| 2017
|
DNA-PkCS expression in oropharyngeal squamous cell carcinoma: Correlations with human papillomavirus status and recurrence after transoral robotic surgery
2017
|
|
| 2017
|
Implementation and utilization of the molecular tumor board to guide precision medicine.
Oncotarget.
8:57845-57854.
2017
|
|
| 2017
|
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.
Oncotarget.
8:21710-21718.
2017
|
|
| 2017
|
Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
British Journal of Cancer.
117:1303-1313.
2017
|
|
| 2016
|
Potential biomarkers for radiosensitivity in head and neck cancers.
Annals of translational medicine.
4.
2016
|
|
| 2016
|
Notch signaling activation is associated with patient mortality and increased FGF1-mediated invasion in squamous cell carcinoma of the oral cavity.
Molecular Cancer Research.
14:883-891.
2016
|
|
| 2016
|
Kinase gene expression profiling of metastatic clear cell renal cell carcinoma tissue identifies potential new therapeutic targets.
PLoS One.
11.
2016
|
|
| 2016
|
Current and emerging clinical applications of multispectral optoacoustic tomography (MSOT) in oncology.
Clinical Cancer Research.
22:3432-3439.
2016
|
|
| 2016
|
The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.
Oncogene.
35:833-845.
2016
|
|
| 2016
|
Niclosamide and its analogs are potent inhibitors of Wnt/ß- catenin, mTOR and STAT3 signaling in ovarian cancer.
Oncotarget.
7:86803-86815.
2016
|
|
| 2016
|
Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinoma.
Prostate Cancer.
2016.
2016
|
|
| 2016
|
Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine.
Prostate Cancer.
2016.
2016
|
|
| 2015
|
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.
Seminars in Cancer Biology.
35:S5-S24.
2015
|
|
| 2015
|
Enhancement of Cetuximab-Induced Radiosensitization by JAK-1 Inhibition.
BMC Cancer.
15.
2015
|
|
| 2015
|
Effect of African-American Race on Tumor Recurrence after Radical Cystectomy for Urothelial Carcinoma of the Bladder.
Clinical Genitourinary Cancer.
13:469-475.
2015
|
|
| 2015
|
The protective effect of p16 INK4a in oral cavity carcinomas: p16 Ink4A dampens tumor invasion-integrated analysis of expression and kinomics pathways.
Modern Pathology.
28:631-653.
2015
|
|
| 2015
|
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers.
Breast Cancer Research and Treatment.
150:569-579.
2015
|
|
| 2015
|
Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
International Journal of Oncology.
46:1079-1088.
2015
|
|
| 2015
|
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm
2015
|
|
| 2015
|
DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.
Oncotarget.
6:26995-27007.
2015
|
|
| 2015
|
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Seminars in Cancer Biology.
35:S276-S304.
2015
|
|
| 2015
|
Synthetic sickness with molecularly targeted agents against the egfr pathway.
Cancer Drug Discovery and Development.
83:381-412.
2015
|
|
| 2014
|
Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.
Urology.
84:1383-1388.
2014
|
|
| 2014
|
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy.
Radiation Oncology.
9.
2014
|
|
| 2014
|
Concentration calibration of urine biomarkers for diagnosis improvement of ovarian cancer.
International Journal of Bio-Science and Bio-Technology.
6:65-72.
2014
|
|
| 2014
|
Epigenetic inactivation of DNA repair in breast cancer.
Cancer Letters.
342:213-222.
2014
|
|
| 2014
|
Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage
2014
|
|
| 2014
|
An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer.
Gynecologic Oncology.
134:331-337.
2014
|
|
| 2014
|
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.
Radiotherapy and Oncology.
111:468-474.
2014
|
|
| 2014
|
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.
Urologic Oncology: seminars and original investigations.
32:687-693.
2014
|
|
| 2014
|
The Smad7-Skp2 complex orchestrates Myc stability, impacting on the cytostatic effect of TGF-β.
Journal of Cell Science.
127:411-421.
2014
|
|
| 2013
|
Beyond DNA repair: Additional functions of PARP-1 in cancer.
Frontiers in Oncology.
3 NOV.
2013
|
|
| 2013
|
PARP-1: Friend or foe of DNA damage and repair in tumorigenesis?.
Cancers.
5:943-958.
2013
|
|
| 2013
|
Segmentation editing improves efficiency while reducing inter-expert variation and maintaining accuracy for normal brain tissues in the presence of space-occupying lesions.
Physics in Medicine and Biology.
58:4071-4097.
2013
|
|
| 2013
|
BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycle.
Journal of Biological Chemistry.
288:8966-8976.
2013
|
|
| 2013
|
Discussion of PARP inhibitors in cancer therapy.
Pharmaceutical Patent Analyst.
2:755-766.
2013
|
|
| 2013
|
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
Clinical Cancer Research.
19:170-182.
2013
|
|
| 2012
|
Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.
Cancer Research.
72:5547-5555.
2012
|
|
| 2012
|
Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells.
PLoS One.
7.
2012
|
|
| 2012
|
HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.
Cancer Research.
72:4796-4806.
2012
|
|
| 2012
|
The intersection between DNA damage response and cell death pathways
2012
|
|
| 2012
|
Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.
Current Molecular Medicine.
12:788-803.
2012
|
|
| 2012
|
Kinomic profiling approach identifies Trk as a novel radiation modulator.
Radiotherapy and Oncology.
103:380-387.
2012
|
|
| 2012
|
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Clinical Cancer Research.
18:3030-3041.
2012
|
|
| 2012
|
Assaying DNA damage in hippocampal neurons using the comet assay..
Journal of Visualized Experiments.
2012
|
|
| 2012
|
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry..
Prostate Cancer.
2012:546794.
2012
|
|
| 2011
|
Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Radiotherapy and Oncology.
101:183-189.
2011
|
|
| 2011
|
Cetuximab augments cytotoxicity with poly (ADP-Ribose) polymerase inhibition in head and neck cancer.
PLoS One.
6.
2011
|
|
| 2011
|
p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.
Cancer Research.
71:5546-5557.
2011
|
|
| 2011
|
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: A multi-expert study.
Physics in Medicine and Biology.
56:4557-4577.
2011
|
|
| 2011
|
Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
Radiotherapy and Oncology.
99:339-343.
2011
|
|
| 2011
|
The poly(ADP-ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Radiotherapy and Oncology.
99:331-338.
2011
|
|
| 2011
|
Glycogen synthase kinase 3β inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons.
Neuro-Oncology.
13:459-470.
2011
|
|
| 2011
|
Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors..
Frontiers in Molecular Neuroscience.
4:47.
2011
|
|
| 2010
|
BRCA1 16 years later: DNA damage-induced BRCA1 shuttling
2010
|
|
| 2010
|
DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.
Cancer Research.
70:6258-6267.
2010
|
|
| 2010
|
Reduction of Dose Delivered to Organs at Risk in Prostate Cancer Patients via Image-Guided Radiation Therapy
2010
|
|
| 2009
|
Evolution of clinical trials in head and neck cancer
2009
|
|
| 2009
|
Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.
Journal of Clinical Investigation.
119:1124-1135.
2009
|
|
| 2009
|
Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course..
Head and Neck Oncology.
1:18.
2009
|
|
| 2008
|
Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.
Cancer Research.
68:9141-9146.
2008
|
|
| 2007
|
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Drug Resistance Updates.
10:135-143.
2007
|
|
| 2007
|
The role of mTOR inhibition in augmenting radiation induced autophagy.
Technology in Cancer Research and Treatment.
6:443-447.
2007
|
|
| 2005
|
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety.
Journal of Clinical Oncology.
23:6730-6738.
2005
|
|
| 2004
|
Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells.
Oncogene.
23:5513-5522.
2004
|
|
| 2003
|
Vitamin D Inhibits G1 to S Progression in LNCaP Prostate Cancer Cells through p27Kip1 Stabilization and Cdk2 Mislocalization to the Cytoplasm.
Journal of Biological Chemistry.
278:46862-46868.
2003
|
|
| 2002
|
Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.
Molecular and Cellular Endocrinology.
186:69-79.
2002
|
|
| 1999
|
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
Cancer Research.
59:3855-3860.
1999
|
|
